Neurocrine Biosciences has presented the first retrospective case series of CRENESSITY in patients with classic congenit...
Lundbeck has presented preliminary Phase II Part A data for asedebart, an investigational anti-adrenocorticotropic hormo...
CARsgen Therapeutics has presented new clinical data for two allogeneic CAR-T cell therapy candidates, CT0596 and CT1190...
In a landmark achievement in biological imaging, researchers at Biohub and the University of California, Berkeley today ...
Sanofi has received European Commission approval for subcutaneous Sarclisa, or isatuximab, in combination with standard-...
MEDIPOST has secured FDA agreement to conduct a single pivotal Phase III study for CARTISTEM in the US, marking an impor...
Regenerative medicine is steadily redefining the future of cardiovascular care, with cell based therapies moving beyond ...
Cell and gene therapies have demonstrated remarkable clinical potential, but translating scientific breakthroughs into w...
As cell and gene therapies transition from clinical development to commercial reality, the industry's attention is incre...
Researchers at King Abdullah University of Science and Technology (KAUST), Saudi Arabia, have developed a new method to ...
Miracell, a South Korea-based stem cell technology company, has obtained US FDA 510(k) clearance for its stem cell extra...
Matricelf, a biotechnology startup based in Israel developing a novel autologous engineered neural tissue therapy for pa...
Achondroplasia, the most common form of genetic dwarfism, has historically relied on treatment approaches that require f...
Japan-based Reprocell has announced the launch of its US FDA compliant Good Manufacturing Practice (GMP) Master Cell Ban...
In this exclusive conversation with BioSpectrum Asia, Alexander Seyf, CEO and Co founder of Autolomous, ...
Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Or...
China-based startup ElpasBio Holdings, a leading clinical-stage biotechnology company focused on regenerative medicine, ...
South Korea-based Clonell Therapeutics, Inc. has announced the official launch of the world's first 'Patient-Specific Em...
As drug developers face increasing pressure to lower prices and accelerate time to market, global biopharmaceutical cont...
Japan-based startup Celaid Therapeutics Inc. has executed a collaborative research agreement with AGC Inc. to advance&nb...
Mirugen, a preclinical biotechnology startup (re)programming cells to unlock innate cellular repair mechanisms, has a...
ProBio, a leading contract development and manufacturing organization (CDMO) specializing in gene and cell therapy, ...
South Korea based Biostar Stem Cell Technology Research Institute, led by Director Jeong Chan Ra, and jointly operated b...
Leading GMP cell CDMO I Peace, Inc., specialising in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therap...
The University of Queensland (UQ) in Australia will host a $238 million industry-led research centre to accelerate indus...
